H2 blocker drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the U.S. for acid reflux, pose no significant risks for the fetus, according to a large collaborative cohort study by researchers in Israel.
H2 blocker drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the U.S. for acid reflux, pose no significant risks for the fetus, according to a large collaborative cohort study by researchers in Israel.